Catalyst Wire Dossier Catalyst Wire Dossier

AZD9291

osimertinib · AstraZeneca
Drug timelines are a Plus or Pro feature.

13 regulatory and trial events tracked for AZD9291, covering 2015-12-31 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: AZD9291 in Combination With Ascending Doses of Novel Therapeutics [Phase 1]

See pricing